Saturday, Jun 20, 2026

Breaking

Home
Business
Entertainment
News
Sports
Tech
World

Explore by Topics

Subscribe

Search

Business
Entertainment
News
Sports
Tech
World

© 2026 El-Balad.com. All Rights Reserved.

Subscribe Newsletter

Daily Stories
Stock Alerts
Full Access

Subscribe to our newsletter to get our newest articles instantly!

I have read and agree to the terms & conditions

Itvisma

FDA Approves Novartis’s Itvisma: First Gene Therapy for SMA Patients 2+

Business

FDA Approves Novartis’s Itvisma: First Gene Therapy for SMA Patients 2+

November 25, 2025

The Daily Newsletter

Brings you a selection of the latest news, trends, insights, and tips from around the world.

I have read and agree to the terms & conditions

El-Balad.com is your trusted source for comprehensive and balanced news coverage. With a commitment to integrity and accuracy, we provide in-depth reporting that uncovers the stories that matter most.

Business
Entertainment
News
Sports
Tech
World

More Links

About
Contact
Privacy